Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001764013-25-000026
Filing Date
2025-02-06
Accepted
2025-02-06 06:45:11
Documents
61
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q imvt-20241231.htm   iXBRL 10-Q 1322693
2 EX-10.1 exhibit101-20241231q3.htm EX-10.1 71081
3 EX-31.1 exhibit311-20241231q3.htm EX-31.1 9759
4 EX-31.2 exhibit312-20241231q3.htm EX-31.2 9756
5 EX-32.1 exhibit321-20241231q3.htm EX-32.1 4465
6 EX-32.2 exhibit322-20241231q3.htm EX-32.2 4486
12 GRAPHIC imvt-20241231_g1.jpg GRAPHIC 146609
13 GRAPHIC imvt-20241231_g2.jpg GRAPHIC 155502
  Complete submission text file 0001764013-25-000026.txt   5950553

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20241231.xsd EX-101.SCH 28422
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imvt-20241231_cal.xml EX-101.CAL 39742
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imvt-20241231_def.xml EX-101.DEF 203199
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20241231_lab.xml EX-101.LAB 475188
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20241231_pre.xml EX-101.PRE 341905
64 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20241231_htm.xml XML 403942
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

EIN.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38906 | Film No.: 25595376
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)